[Product Releases]
|
|
|
|
|
[Blog]
|
|
Most recent post
|
[News]
|
|
Can we trust docking results? Sept 2010 IBM Systems and Technology Group releases a white paper with eHiTS and Cell
Oct 2008
EPA's ToxCastTM project will use SimBioSys' eHiTS as docking engine
Nov, 2007
|
[Events]
|
| 240th ACS
Aug 22-26, 2010 Boston, MA, USA
booth #945
see >> more
|
|
|
|
|
Benefit Highlights
|
 |
Sprout's HIPPO module is uniquely
able to recognize
specific catalytic patterns and suggest covalent interaction sites
accordingly.
|
 |
-
Special Ligand
Interaction Surface
More sophisticated than double
VDW, Sprout generates
a VDW + probe radius varied by interaction type (lipo, polar, H-bond,
covalent)
as presented at the York MGMS conference in 1995.
|
 |
Powerfully, users are able to run
components automatically
or maintain control to guide and modify each decision of every module
for
maximum versatility.Customers
have
chosen SPROUT over other de novo programs for much greater control of
the
search.
|
 |
-
Excellent Interaction
Visualization
Sprout's surface representations are
colour coded according
to interaction type and not by atom type. Target site
interaction
regions can be visualized with tolerances. Clients
often use SPROUT for visualization even during tasks that are not de
novo
design related (e.g. lead optimisation), because it visualizes the
receptor-ligand
interactions better than any other tool available.
|
 |
As opposed to the discrete sampling of
interaction points found
in other tools, the interaction regions are represented and the space
is
searched continously.
|
 |
-
Systematic, Exhaustive
Search
Guarantees that all possible
solutions will be found
within the limits defined by the constraints and parameters. In
contrast,
other de novo packages are limited by random number generators and
linker
fragment DBs.
|
 |
-
Specific Library for
Peptide Generation
Specific library to quickly generate
peptides only. The use
of this library is optional, i.e. the program can be still used with
the
standard library to generate a wide variety of small molecule drug
candidates.
|
|
|
|